Table 2.
Important characteristics and course of disease in the five patients with peripheral T‐cell lymphoma
| Histology | Sex | Age | ECOG | Previous therapy lines | Response | PFS (months) | OS (months) | Relapse | |
|---|---|---|---|---|---|---|---|---|---|
| Patient 1 | PTCL, NOS | F | 75 | 0 | 1 | Death after one cycle | 0 | 0 | – |
| Patient 2 | ALCL | M | 65 | 0 | 2 | CR | 21 | 21 | No |
| Patient 3 | PTCL, NOS | F | 77 | 0 | 0 | CR | 20 | 20 | Yes |
| Patient 4 | composite (PTCL, NOS + HL) | M | 54 | 1 | 1 | Death after 3 cycles | 4 | 4 | – |
| Patient 5 | Lennert's lymphoma | M | 76 | 0 | 1 | CR | 5 | 5 | No |
Abbreviations: ALCL, anaplastic large cell lymphoma; HL, Hodgkin lymphoma; NOS, not otherwise specified; PTCL, peripheral T‐cell lymphoma.